Does PALBOCICLIB Cause Haematocrit decreased? 357 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 357 reports of Haematocrit decreased have been filed in association with PALBOCICLIB (Ibrance). This represents 0.4% of all adverse event reports for PALBOCICLIB.
357
Reports of Haematocrit decreased with PALBOCICLIB
0.4%
of all PALBOCICLIB reports
21
Deaths
77
Hospitalizations
How Dangerous Is Haematocrit decreased From PALBOCICLIB?
Of the 357 reports, 21 (5.9%) resulted in death, 77 (21.6%) required hospitalization, and 5 (1.4%) were considered life-threatening.
Is Haematocrit decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 357 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Haematocrit decreased?
CLOZAPINE (1,027)
RUXOLITINIB (562)
ECULIZUMAB (466)
ADALIMUMAB (455)
NIRAPARIB (406)
METHOTREXATE (396)
RITUXIMAB (328)
ALEMTUZUMAB (283)
PREDNISONE (283)
TISAGENLECLEUCEL (264)
Which PALBOCICLIB Alternatives Have Lower Haematocrit decreased Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID